Home › Funds › Forvis Mazars Wealth Advisors, LLC › JNJ

Forvis Mazars Wealth Advisors, LLC position in JNJ

JOHNSON JOHNSON · Health Care

Forvis Mazars Wealth Advisors, LLC reported holding 56,896 shares of JNJ (JOHNSON JOHNSON) in its Q3 2026 13F filing — a position valued at US$15.1M, representing 0.25% of its reported portfolio and ranking #48 among its reported holdings. Forvis Mazars Wealth Advisors, LLC has disclosed JNJ holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)56.90K sh
Reported value held$15.06M
Portfolio Weight0.25%
First reportedQ3 2023
Last changeHold
Updated2026-10-14

Last updated: 2026-10-14 · Source: SEC EDGAR Form 13F-HR

How Forvis Mazars Wealth Advisors, LLC's JNJ position evolved

Forvis Mazars Wealth Advisors, LLC first disclosed a stake in JNJ in Q3 2023 at 44,422 shares (US$6.9M). The position peaked in Q3 2026 at 56,896 shares, worth US$15.1M. Across 13 filings, Forvis Mazars Wealth Advisors, LLC increased the stake 3 time(s), trimmed it 5 time(s) and left it unchanged 4 time(s). The most recent filing (Q3 2026) shows 56,896 shares valued at US$15.1M. Notable position changes include a 29% increase in Q1 2024 (shares fell 8% over the following quarter), a 31% trim in Q3 2024 (shares fell 11% over the following quarter), a 38% increase in Q1 2025 (shares fell 6% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 44.42K $6.92M New
Q4 2023 42.76K $6.70M Reduce
Q1 2024 55.05K $8.71M Add
Q2 2024 63.37K $9.26M Add
Q3 2024 43.59K $7.06M Reduce
Q4 2024 42.64K $6.17M Reduce
Q1 2025 58.66K $9.73M Add
Q2 2025 57.43K $8.77M Reduce
Q3 2025 56.40K $10.46M Reduce
Q4 2025 56.58K $11.71M Hold
Q1 2026 56.69K $13.86M Hold
Q2 2026 56.94K $14.46M Hold
Q3 2026 56.90K $15.06M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About JNJ and 13F data

JNJ (JOHNSON JOHNSON) is a Health Care company. 33 other funds we track also report a position in JNJ — the largest reported positions include BlackRock Inc (US$53.87B), Vanguard Group (US$49.74B), VANGUARD CAPITAL MANAGEMENT LLC (US$39.93B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding JNJ

All JNJ fund holders →

FAQ

How long has Forvis Mazars Wealth Advisors, LLC held JNJ?

Forvis Mazars Wealth Advisors, LLC has disclosed JNJ holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Forvis Mazars Wealth Advisors, LLC's current position in JNJ?

As of Q3 2026, Forvis Mazars Wealth Advisors, LLC holds 56.90K shares of JNJ (JOHNSON JOHNSON), valued at $15.06M, representing 0.25% of its reported portfolio and ranking #48.

Has Forvis Mazars Wealth Advisors, LLC been buying or selling JNJ?

In the latest 13F filing (Q3 2026), Forvis Mazars Wealth Advisors, LLC held unchanged its position in JNJ. The position peaked in Q3 2026 at 56.90K shares.

Which other funds hold JNJ?

Other major institutional holders of JNJ include BlackRock Inc, Vanguard Group, VANGUARD CAPITAL MANAGEMENT LLC, among 33 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.